retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Retatrutide's mechanisms of action Targeting GLP-1, GIP & GCG

Therefore, this hormone could be a promising candidate for combination therapy with GLP-1 for better control of T2D

- Oral semaglutide is effective, safe and well tolerated in patients with DM2, even in those with DKD, with the benefits inherent to this family of drugs, which may facilitate the earlier introduction of an arGLP-1 in the management of DM2

This has obvious benefits for those with Type 2 diabetes, but it can also help those who struggle with insulin resistance and weight maintenance

Future research should address these limitations by including a more comprehensive range of studies, providing detailed GLP-1RAs classification information, and reporting precise dosages used in the treatment protocols

So how do these benefits occur

Short walks two or three times a day are just as good as one longer walk